M. J. Biopharm Profile
Key Indicators
- Authorised Capital ₹ 40.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 23.01 Cr
as on 24-10-2024
- Company Age 22 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 151.00 Cr
as on 24-10-2024
- Satisfied Charges ₹ 42.78 Cr
as on 24-10-2024
- Revenue 15.73%
(FY 2023)
- Profit 27.68%
(FY 2023)
- Ebitda 15.39%
(FY 2023)
- Net Worth 9.38%
(FY 2023)
- Total Assets 21.88%
(FY 2023)
About M. J. Biopharm
The Corporate was formerly known as Mj Biogen Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 40.00 Cr and a paid-up capital of Rs 23.01 Cr.
The company currently has active open charges totaling ₹151.00 Cr. The company has closed loans amounting to ₹42.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at M. J. Biopharm Private Limited India is Pradakshina Goswami as COMPANY SECRETARY. Amol Shah, Pheroze Mistry, Kajal Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U24234PN2002PTC158855
- Company No.
158855
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jun 2002
- Date of AGM
28 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does M. J. Biopharm Private Limited offer?
M. J. Biopharm Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Diabetes Medicine.
Who are the key members and board of directors at M. J. Biopharm?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amol Shah  | Managing Director | 09-Nov-2010 | Current |
| Pradakshina Goswami | Company Secretary | 08-May-2023 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kajal Shah | Director | 24-Mar-2022 | Current |
| Dhaval Vashi | Director | 10-Dec-2012 | Current |
| Pheroze Mistry | Nominee Director | 04-May-2018 | Current |
Financial Performance and Corporate Structure Insights of M. J. Biopharm.
M. J. Biopharm Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.73% increase. The company also saw a substantial improvement in profitability, with a 27.68% increase in profit. The company's net worth moved up by a moderate rise of 9.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of M. J. Biopharm?
In 2023, M. J. Biopharm had a promoter holding of 70.00% and a public holding of 30.00%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pallonji Investment And Finance Private LimitedActive 48 years 7 monthsPheroze Mistry is a mutual person
Pallonji Industrial Finishers Private LimitedActive 34 years 4 monthsPheroze Mistry is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sbicap Trustee Company Limited Creation Date: 31 May 2022 | ₹151.00 Cr | Open |
Others Creation Date: 04 Dec 2015 | ₹3.00 Cr | Satisfied |
Icici Bank Limited Creation Date: 17 Nov 2015 | ₹5.00 Cr | Satisfied |
How Many Employees Work at M. J. Biopharm?
M. J. Biopharm has a workforce of 315 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M. J. Biopharm, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M. J. Biopharm's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
